{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:44:33Z","timestamp":1791499473825,"version":"4.3.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00064","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T23:58:20Z","timestamp":1582070300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":155,"title":["Asprosin: A Novel Player in Metabolic Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Mingyang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a fasting-induced glucogenic protein hormone","volume":"165","author":"Romere","year":"2016","journal-title":"Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.gene.2016.07.033","article-title":"FBN1: the disease-causing gene for marfan syndrome and other genetic disorders","volume":"591","author":"Sakai","year":"2016","journal-title":"Gene."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/hmg\/7.13.2039","article-title":"Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations","volume":"7","author":"Lonnqvist","year":"1998","journal-title":"Hum Mol Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1172\/JCI117930","article-title":"A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the marfan syndrome","volume":"95","author":"Milewicz","year":"1995","journal-title":"J Clin Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","article-title":"Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation","volume":"486","author":"Lee","year":"2019","journal-title":"Mol Cell Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nm.4432","article-title":"Asprosin is a centrally acting orexigenic hormone","volume":"23","author":"Duerrschmid","year":"2017","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"116554","DOI":"10.1016\/j.lfs.2019.116554","article-title":"Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1\/2-SOD2 pathway","volume":"231","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20888","DOI":"10.1002\/jcp.28694","article-title":"Asprosin attenuates insulin signaling pathway through PKCdelta-activated ER stress and inflammation in skeletal muscle","volume":"234","author":"Jung","year":"2019","journal-title":"J Cell Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"C2","DOI":"10.1016\/j.jacc.2018.08.012","article-title":"The protective role of Asprosin against diabetes in cardiomyocytes","volume":"72","author":"Feng","year":"2018","journal-title":"J Am Colle Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5483\/BMBRep.2015.48.4.272","article-title":"Network of hypothalamic neurons that control appetite","volume":"48","author":"Sohn","year":"2015","journal-title":"BMB Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2019.05.022","article-title":"OLFR734 Mediates glucose metabolism as a receptor of asprosin","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metabol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2019.02.004","article-title":"Case reports of pre-clinical replication studies in metabolism and diabetes","volume":"29","author":"von Herrath","year":"2019","journal-title":"Cell Metabol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"Amer Diabet","year":"2014","journal-title":"Diabetes Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"9471583","DOI":"10.1155\/2018\/9471583","article-title":"Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion","volume":"2018","author":"Wang","year":"2018","journal-title":"Med Inflam."},{"key":"B15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","article-title":"Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride","volume":"489","author":"Zhang","year":"2019","journal-title":"Clin Chim Acta."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13148","article-title":"Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus","author":"Zhang","year":"2019","journal-title":"J Diabetes Investig."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7375294","DOI":"10.1155\/2018\/7375294","article-title":"Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases","volume":"2018","author":"Li","year":"2018","journal-title":"Med Inflam."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0222771","DOI":"10.1371\/journal.pone.0222771","article-title":"Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes","volume":"14","author":"Groener","year":"2019","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"170132","DOI":"10.1016\/j.peptides.2019.170132","article-title":"Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus","volume":"120","author":"Baykus","year":"2019","journal-title":"Peptides."},{"key":"B20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/jcm8050666","article-title":"Aerobic exercise training decreases hepatic asprosin in diabetic rats","volume":"8","author":"Ko","year":"2019","journal-title":"J Clin Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tem.2003.09.008","article-title":"Lipid overload and overflow: metabolic trauma and the metabolic syndrome","volume":"14","author":"Unger","year":"2003","journal-title":"Trends Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","article-title":"Serum asprosin levels and bariatric surgery outcomes in obese adults","volume":"43","author":"Wang","year":"2019","journal-title":"Int J Obesity."},{"key":"B24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000503808","article-title":"Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity","volume":"75","author":"Wang","year":"2019","journal-title":"Ann Nutr Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2521096","DOI":"10.1155\/2019\/2521096","article-title":"Saliva and blood asprosin hormone concentration associated with obesity","volume":"2019","author":"Ugur","year":"2019","journal-title":"Int J Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fphar.2018.00156","article-title":"Peripheral CB1 receptor neutral antagonist, AM6545, ameliorates hypometabolic obesity and improves adipokine secretion in monosodium glutamate induced obese mice","volume":"9","author":"Ma","year":"2018","journal-title":"Front Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000500523","article-title":"Decreased circulating levels of asprosin in obese children","volume":"91","author":"Long","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","article-title":"Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome","volume":"35","author":"Alan","year":"2019","journal-title":"Gynecol Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1038\/s41598-019-42061-9","article-title":"The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients","volume":"9","author":"Chang","year":"2019","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: statistics from world health organisation and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int J Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejcts.2006.01.047","article-title":"Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. insights from the SYNTAX run-in phase","volume":"29","author":"Kappetein","year":"2006","journal-title":"Eur J Cardiothorac Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2017.12.032","article-title":"A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris: asprosin","volume":"36","author":"Acara","year":"2018","journal-title":"Am J Emerg Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12975-012-0251-0","article-title":"Preconditioning strategy in stem cell transplantation therapy","volume":"4","author":"Yu","year":"2013","journal-title":"Transl Stroke Res."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00064\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T23:58:22Z","timestamp":1582070302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00064\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":34,"alternative-id":["10.3389\/fendo.2020.00064"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00064","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"article-number":"64"}}